Fortrea Holdings Inc.
Fortrea Holdings Inc. (FTRE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FTRE · as of Jun 8, 2026
Key Statistics
Explore Fortrea Holdings Inc. Data
ftre stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 41.7%
The FTRE analyst consensus is Hold, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $18.57, representing +15.49% upside from the current price of $16.08.
Competitors & Peers
ftre competitorsFTRE
ANAB
AVBP
BBOT
EYPT
KURAStock Performance
Full HistoryAbout Fortrea Holdings Inc.
Fortrea Holdings Inc. a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segm…
what is fortrea holdings inc. · ftre stock overview · fortrea holdings inc. company profile · who is fortrea holdings inc. ceo · ftre NASDAQ · fortrea holdings inc. headquarters · fortrea holdings inc. business segments
About Stock Overview & Key Data
Fortrea Holdings Inc. (FTRE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 20, 2023. As of the latest trading session, FTRE stock price is $16.08, with a market capitalization of $1.6B. The stock has returned +211.72% over the past 12 months and -0.61% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Fortrea Holdings Inc. stock is Hold, with an average 12-month price target of $18.57. In fiscal year 2025, Fortrea Holdings Inc. reported revenue of $2.7B and net income of -$986.2M. For detailed data — including Fortrea Holdings Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Fortrea Holdings Inc. (FTRE) stock price is $16.08. The stock is traded on NASDAQ under the ticker symbol FTRE. The 52-week range is $4.36 – $18.67.